TOOsonix
  • Home
  • Products
    • System ONE-M
    • System ONE-R
  • Technology
    • How it works
    • Before and after treatment
  • News
  • Publications
  • Clinical Trials
  • Downloads
  • About us
  • Contact us
    • FAQ
    • Downloads
  • Menu Menu

Presentation of ground-breaking clinical results from GCP study on most common orphan disease

June 24, 2023/in News/by Torsten Bove
Read more
Tags: cNF, Conference, HIFU, NF1
https://toosonix.com/wp-content/uploads/2024/05/cTF2023-Square.png 649 800 Torsten Bove https://toosonix.com/wp-content/uploads/2024/05/TOOsonix-Logo-1_Low-1-1.png Torsten Bove2023-06-24 07:52:062026-04-13 11:53:57Presentation of ground-breaking clinical results from GCP study on most common orphan disease

Oral presentation at the Childrens Tumor Foundation conference 2023, the world’s largest venue addressing the clinical status and development for the genetic disease Neurofibromatosis (NF).

High Intensity Focused Ultrasound (HIFU) treatment of Cutaneous Neurofibromas cNF: Preliminary results from a prospective dual center clinical investigation.

Dr. Katrine Karmisholt, MD, PhD, Bispebjerg University Hospital, Denmark.

The study is funded by the neurofibromatosis acceleration program (NTAP) at Johns Hopkins University, MD, USA (link)

Download abstract here

Foundation internet page here

Please contact us directly to receive a copy of the presentation and/or video.

You might also like
RELEASE OF MEDICAL PRODUCT: TOOsonix System ONE-M.
TOOsonix Expands Distribution to the United Arab Emirates
Join Us at the Leading Dermoscopy Conference in Łódź, Poland – April 4-5, 2025!
First patient treated with TOOsonix HIFU in skin cancer study.
TOOsonix handpiece and acoustic measurements featured on front page of leading scientific journal
TOOsonix therapy now at Helsinki University Hospital
TOOsonix treatment effectively resolve common aesthetic skin condition
TOOsonix papers among top sited in journals from Wiley and Sons Inc.

ARCHIVE

  • April 2026
  • January 2026
  • December 2025
  • October 2025
  • August 2025
  • May 2025
  • March 2025
  • February 2025
  • October 2024
  • September 2024
  • June 2024
  • May 2024
  • April 2024
  • February 2024
  • January 2024
  • October 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • June 2022
  • April 2022
  • March 2022
  • January 2022
  • December 2021
  • November 2021
  • August 2021
  • July 2021
  • June 2021
  • March 2021
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • February 2020
  • January 2019

CATEGORIES

  • Conference
  • News
  • Presentations
  • Publications

ADDRESS

Agern Allé 1
2970 Horsholm
Denmark

Phone: (+45) – 2059 2999
E-mail: info@toosonix.com

Privacy policy

MENU

  • Products
    • System ONE-M
    • System ONE-R
  • Publications
  • Clinical Trials
  • News
  • About us
  • Contact us
Link to: Second US Patent for TOOsonix technology granted Link to: Second US Patent for TOOsonix technology granted Second US Patent for TOOsonix technology granted Link to: Key-note Speaker at Ultrasonics 2023, Portugal Link to: Key-note Speaker at Ultrasonics 2023, Portugal Key-note Speaker at Ultrasonics 2023, Portugal
Scroll to top Scroll to top Scroll to top

This site uses cookies. By clicking ‘Accept all’, you give your consent for all these purposes

Accept allSettings

Cookie and Privacy Settings



How we use cookies

We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy
Save settingsHide notification only
Open Message Bar Open Message Bar Open Message Bar